Girschikofsky, M., Arico, M., Castillo, D., Chu, A., Doberauer, C., Fichter, J., Haroche, J., Kaltsas, G.A., Makras, P., Marzano, A.V., de Menthon, M., Micke, O., Passoni, E., Seegenschmiedt, H.M., Tazi, A. and McClain, K.L. (2013) Management of Adult Patients with Langerhans Cell Histiocytosis: Recommendations from an Expert Panel on Behalf of Euro-Histio-Net. Orphanet Journal of Rare Diseases, 8, Article No. 72.
https://doi.org/10.1186/1750-1172-8-72

has been cited by the following article:

• TITLE: Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report

  AUTHORS: Emad Mohsen Barsoum, Fiby Samir Boules, May Gamal Ashour, Mohsen Samy Barsoum

  KEYWORDS: Erdheim-Chester Disease, Histiocytoses, Non-Langerhans Cell Histiocytoses

  JOURNAL NAME: Journal of Cancer Therapy, Vol.12 No.12, December 13, 2021

  ABSTRACT: Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51-year-old male patient treated with pegylated IFN-α in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects.